Jason Botten and Emily Bruce, who pioneered a streamlined COVID-19 test that doesn’t use scarce chemicals, in their research lab in the University of Vermont’s Larner College of Medicine. The machine between them is used to measure the presence and quantity of viral RNA in patient samples. (Photo: Brian Jenkins)
Addresses Major Testing Need in Developing World; Also in U.S., Where Reagent Supplies Are Again Dwindling
A major roadblock to large scale testing for coronavirus infection in the developing world is a shortage of key chemicals, or reagents, needed for the test, specifically the ones used to extract the virus’s genetic material, or RNA.
A team of scientists at the University of Vermont, working in partnership with a group at the University of Washington, has developed a method of testing for the COVID-19 virus that doesn’t make use of these chemicals but still delivers an accurate result, paving the way for inexpensive, widely available testing in both developing countries and industrialized nations like the United States, where reagent supplies are again in short supply.
The method for the test, published October 2 in PLOS Biology, omits the step in the widely used reverse transcription polymerase chain reaction (RT-PCR) test, considered the gold standard of COVID-19 diagnostics, where the scarce reagents are needed.
92% Accuracy, Missing Only Lowest Viral Loads
The accuracy of the new test was evaluated by a team of researchers at the University of Washington led by Keith Jerome, director of the university’s Molecular Virology Lab, using 215 COVID-19 samples that RT-PCR tests had shown were positive, with a range of viral loads, and 30 that were negative.
It correctly identified 92% of the positive samples and 100% of the negatives.
The positive samples the new test failed to catch had very low levels of the virus. Public health experts increasingly believe that ultra-sensitive tests that identify individuals with even the smallest viral loads are not needed to slow spread of the disease.
“It was a very positive result,” said Jason Botten, an expert on pathogenic RNA viruses at the University of Vermont’s Larner College of Medicine and senior author on the PLOS Biology paper. Botten’s colleague Emily A. Bruce is the paper’s first author.
“You can go for the perfect test, or you can use the one that’s going to pick up the great majority of people and stop transmission,” Botten said. “If the game now is focused on trying to find people who are infectious, there’s no reason why this test shouldn’t be front and center, especially in developing countries where there are often limited testing programs because of reagent and other supply shortages.”
Skipping a step
The standard PCR test has three steps, while this simpler version of the standard test has only two, Botten said.
“In step 1 of the RT-PCR test, you take the swab with the nasal sample, clip the end and place it in a vial of liquid, or medium. Any virus on the swab will transfer from the swab into the medium,” he said. “In step 2, you take a small sample of the virus-containing medium and use chemical reagents, the ones that are often in short supply, to extract the viral RNA. In step 3, you use other chemicals to greatly amplify any viral genetic material that might be there. If virus was present, you’ll get a positive signal.”
The new test skips the second step.
“It takes a sample of the medium that held the nasal swab and goes directly to the third, amplification step,” Botten said, removing the need for scarce RNA extraction reagents as well as significantly reducing the time, labor and costs required to extract viral RNA from the medium in step 2.
Botten said the test is ideally suited to screening programs, in both developed and developing countries, since it is inexpensive, takes much less processing time and reliably identifies those who are likely to spread the disease.
Its low cost and efficiency could extend testing capacity to groups not currently being tested, Botten said, including the asymptomatic, nursing home residents, essential workers and school children. The standard RT-PCR test could be reserved for groups, like health care workers, where close to 100% accuracy is essential.
An influential pre-print points the way to widespread adoption of test
The two-step test developed by the University of Vermont team first caught the attention of the scientific community in March, when preliminary results that accurately identified six positive and three negative Vermont samples were published as a preprint in bioRxiv, an open access repository for the biological sciences. The preprint was downloaded 18,000 times — in its first week, it ranked 17th among 15 million papers the site had published — and the abstract was viewed 40,000 times.
Botten heard from labs around the world who had seen the preprint and wanted to learn more about the new test.
“They said, ‘I’m from Nigeria or the West Indies. We can’t test, and people’s lives are at stake. Can you help us?’”
Botten also heard from Syril Pettit, the director of HESI, the Health and Environmental Sciences Institute, a non-profit that marshals scientific expertise and methods to address a range of global health challenges, who had also seen the preprint.
Pettit asked Botten to join a think tank of likeminded scientists she was organizing whose goal was to increase global testing capacity for COVID-19. The test developed by the University of Vermont and University of Washington teams would serve as a centerpiece.
To catalyze a global response, the group published a call to action in EMBO Molecular Medicine.
And it took action, reaching out to 10 laboratories in seven countries, including Brazil, Chile, Malawi, Nigeria and Trinidad/Tobago, as well as the U.S. and France, to see if they would be interested in giving the two-step test a trial run.
“Universally, the response was yes,” Pettit said.
The outreach led to a new HESI program called PROPAGATE. Each of the labs in the PROPAGATE Network will use the two-step test on a series of positive and negative samples sent to them by the University of Washington to see if they can replicate the results the university achieved.
The study has already shown promising results. One of the labs in Chile has also used the test on its own samples from the community and got accurate results.
Assuming all goes well, Pettit and her colleagues at the University of Vermont and the University of Washington as well as scientists from the 10 partner sites plan to publish the results.
“The goal is the make the two-step test accessible to any lab in the world facing these hurdles and see a broad uptake,” she said.
The Latest Updates from Bing News & Google News
Go deeper with Bing News on:
- Texas Gov. Greg Abbott announces negative COVID-19 test after Regeneron antibody treatmenton August 22, 2021 at 12:47 pm
Texas Gov. Greg Abbott, who was fully vaccinated, tested positive for COVID-19 Tuesday. Abbott was asymptomatic, but received antibody treatment.
- PH Paralympic bet, coaches, officials test positive for COVID-19on August 22, 2021 at 12:47 pm
Team Philippines chef-de-mission Francis Diaz told CNN Philippines the para-athlete who tested positive for COVID-19 is not eligible anymore to compete in the Tokyo Paralympics.
- Titans coach Mike Vrabel tests positive for COVID-19 day after Bucs gameon August 22, 2021 at 12:41 pm
The Tennessee boss is vaccinated and in quarantine after spending quite a bit of time this past week with Tom Brady.
- Cold or COVID-19? Health officials urge testing, even if you don't think you have the viruson August 22, 2021 at 12:41 pm
WBAL NewsRadio 1090/FM 101.5 - Right now, officials at Norton Children's Hospital in Louisville, Kentucky, are treating 17 kids with COVID-19, the most they've ...
- NFL notebook: Titans coach Vrabel test positive for COVID-19on August 22, 2021 at 11:56 am
Tennessee Titans Coach Mike Vrabel said Sunday he has tested positive for COVID-19 and has quarantined pending further testing. Vrabel told reporters he had a sore throat and an earache. He went to ...
Go deeper with Google Headlines on:
Go deeper with Bing News on:
- Tennessee Titans coach Mike Vrabel tests positive for COVID-19 and is quarantining pending further testingon August 22, 2021 at 11:38 am
Tennessee Titans coach Mike Vrabel said Sunday he has tested positive for COVID-19 and has quarantined pending further testing.
- Cold or COVID-19? Health officials urge testing, even if you don't think you have the viruson August 22, 2021 at 11:22 am
Right now, officials at Norton Children's Hospital in Louisville, Kentucky, are treating 17 kids with COVID-19, the most they've ever had. Health officials fear they won't be able to put a proper lid ...
- Rev. Jesse Jackson Sr. And His Wife Both Test Positive For COVID-19on August 22, 2021 at 11:17 am
Our thoughts and prayers go out to Rev. Jesse Jackson Sr. and his wife Jacqueline Jackson. The activist, 79, and Jacqueline, 77 have both been hospitalized after testing positive for COVID-19.
- Texas Gov. Greg Abbott now testing negative for COVID-19, maintains ban on mask mandateson August 22, 2021 at 10:49 am
Texas Gov. Greg Abbott says he has tested negative for COVID-19, just four days after testing positive. “I'm told that my infection was brief and mild because of the vaccination that I received,” ...
- Israel is testing 1.4 million children for COVID-19 antibodieson August 22, 2021 at 9:34 am
Kids between the ages of 3 and 12 will be tested for antibodies in an attempt to measure COVID's undetected spread among Israeli children.